In older, frail, VKA-experienced patients with AF, SD-DOACs vs. warfarin reduced thrombotic events without increasing major bleeding. Ito K. Ann Intern Med 2025;178:JC128.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ito K. In older, frail, VKA-experienced patients with AF, SD-DOACs vs. warfarin reduced thrombotic events without increasing major bleeding. Ann Intern Med 2025;178:JC128.
PMID: 41183339